Module E: CRO Partnerships & Risk Management

16:30 – 17:05
Managing the risks associated with outsourcing clinical research
• Identifying the right partner - evaluating the pros and cons of LCCS providers
• Facilitating the shift from transactional relationships to strategic partnerships
• Developing secrecy agreements and protecting the intellectual property
• Are long term contracts the way to go?
• Speaking the same language - understanding key terms and negotiation strategies

17:05 – 17:40
Case Study
Developing a successful partnership with a LCCS CRO
• A review of the selection process for choosing CRO
• Demonstrating how costs have been reduced in the research process
• Step by step guide to mitigating risks - what we have learnt
• The future - how the relationship will develop
Chris Keep, Director Clinical Outsourcing, AstraZeneca

17:40 – 18:15
Panel Debate
How important will CROs be in the future of the pharmaceutical industry?
• Is the CRO approach the best way to move into biopharma? 
• Exploring the use of preclinical outsourcing to cut internal costs and drive efficiency
• The adoption of EDC as a tool to support outsourcing
• Are CROs the only option to eliminate internal challenges of slow project execution and high costs?
• Is bigger better?  How will small CROs fair in the future?  
 

Return to Agenda